Investment Rating - The report maintains a "Buy" rating for New Oriental-S (09901) [2][7] Core Insights - New Oriental's revenue for 2QFY26 reached USD 1.191 billion, reflecting a year-over-year increase of 14.7%. The education business (including cultural tourism) generated USD 974 million, up 13% YoY, while other businesses (primarily EastBuy) saw revenue of USD 217 million, a 22.9% YoY increase. Non-GAAP net profit attributable to shareholders was USD 73 million, surging 68.6% YoY, with a non-GAAP net margin of 6.1%, expanding by 2 percentage points YoY [5][9] - The overseas study business growth has bottomed out, with revenue from overseas test preparation and consulting at USD 252 million, a 1% YoY increase, indicating a slowdown of 29.3 percentage points compared to the previous year [10] - New business segments, including K9 non-academic tutoring and learning tablets, showed robust growth with a 21.6% YoY increase in revenue to USD 366 million. The number of learning centers increased to 1,379, up 21% YoY [11] - Operating margins are improving, with the non-GAAP operating margin expanding by 4.7 percentage points YoY to 7.5% in 2QFY26. The education business's non-GAAP operating margin was 6.6%, up 3.5 percentage points YoY [12] Financial Data and Profit Forecast - Revenue forecasts for FY26-FY28 have been raised to USD 5.5 billion, USD 6.11 billion, and USD 6.89 billion, respectively. Non-GAAP net profit forecasts for the same period have also been increased to USD 570 million, USD 629 million, and USD 700 million [7][13] - The financial data for FY24 to FY28 indicates a steady growth trajectory, with revenue expected to grow from USD 4.314 billion in FY24 to USD 6.887 billion in FY28, and net profit increasing from USD 464 million to USD 700 million over the same period [16]

Investment Rating - The report maintains a "Buy" rating for the company [4][5]. Core Insights - The company achieved a revenue of approximately 2.31 billion RMB in FY26H1, representing a year-over-year increase of 5.7%, with adjusted net profit reaching 258 million RMB, a significant improvement from a loss of 2 million RMB in FY25H1 [1][10]. - The company's self-operated products have shown strong performance, with their contribution to total GMV rising to 52.8% in FY26H1, up from 43.8% in FY25, indicating a successful shift towards brand transformation [2][10]. - The company is expanding its multi-channel strategy, with plans to open its first offline experience store in Beijing, enhancing customer engagement through a combination of shopping, leisure, and social experiences [3][10]. Financial Performance - The adjusted net profit forecasts for FY26-28 have been raised to 514 million, 535 million, and 603 million RMB, reflecting increases of 36%, 37%, and 43% respectively compared to previous estimates [4][10]. - The gross margin improved to 36.4% in FY26H1, driven by the healthy development of self-operated products and optimization of personnel costs [10]. Market Positioning - The company has successfully diversified its product categories from fresh food to high-demand areas such as nutritional supplements, pet food, and apparel, which has effectively boosted the gross margin of self-operated products [2][10]. - The membership base has grown to 240,100 in FY26H1, up from 228,300 in FY25H1, indicating a strong and expanding user engagement [3][10].

Investment Rating - The report maintains a "BUY" rating for Sunny Optical, with a new target price (TP) of HK$91.38, implying a potential upside of 45.3% from the current price of HK$62.90 [3][14]. Core Insights - Sunny Optical has announced a positive profit alert for FY25E, projecting a net profit growth of 70-75% year-over-year, driven by high-end specification upgrades, improved product mix, and investment income from a deal with Goertek Optical Tech [1][9]. - For FY26, the company expects revenue growth to be supported by trends in smart driving, AI/AR glasses, and high-end camera specifications, which will help offset weaknesses in the smartphone segment due to memory cost pressures [1][9]. - The report indicates a slight reduction in FY26-27E EPS estimates by 1-4% to account for headwinds in the smartphone industry [1][9]. Financial Summary - Revenue projections for FY25E are set at RMB 42,056 million, with a year-over-year growth of 9.8%. For FY26E, revenue is expected to decline slightly to RMB 41,582 million, followed by a recovery to RMB 45,468 million in FY27E [2][22]. - Net profit is forecasted to reach RMB 4,610 million in FY25E, a 70.8% increase year-over-year, but is expected to decrease to RMB 3,909 million in FY26E before rebounding to RMB 4,699 million in FY27E [2][22]. - The report highlights a projected EPS of RMB 4.24 for FY25E, with consensus estimates at RMB 3.25 for the same period [2][11]. Valuation - The new target price of HK$91.38 is derived from a sum-of-the-parts (SOTP) valuation methodology, applying a target P/E multiple of 23.4x FY26E EPS, reflecting the company's diversified business model and growth potential across various segments [3][14][16]. - The report assigns different P/E multiples to various business segments, with 23x for camera modules and handset lenses, and 25x for vehicle lenses, reflecting their respective market positions and growth prospects [15][16].

Investment Rating - The report assigns a "Buy" rating for the company, indicating an expected relative increase of over 15% compared to the Hang Seng Index [7]. Core Insights - The company's revenue for the first three quarters was 39.862 billion RMB, a year-on-year decline of 7.3%, with net profit at 3.052 billion RMB, down 22.1%. However, the third quarter revenue showed a slight decline of only 0.4%, an improvement from the 10% drop in the first half of the year [2]. - The sales in Hainan's duty-free sector from July to September totaled 5.402 billion RMB, a year-on-year decrease of 2.6%, but the decline was less than the previous quarter. Notably, September saw a 3.4% year-on-year increase in sales, marking the first growth in 18 months [2]. - The upcoming peak travel season is expected to drive a recovery in revenue, with double-digit year-on-year growth anticipated in October and November due to new city duty-free store openings and favorable duty-free policies [2]. - The Hainan Free Trade Port officially commenced full island closure operations on December 18, 2025, expanding duty-free benefits to all travelers departing from Hainan. This policy change is expected to significantly boost consumer spending [3]. - The company has acquired DFS's Hong Kong and Macau businesses for over 3 billion RMB, which will enhance its store network in Greater China and create synergies in procurement, logistics, and customer management [4]. - The luxury goods market is showing signs of recovery, which positively impacts duty-free consumption. Sales for some luxury brands in Asia have stabilized, indicating improved consumer willingness to spend [5]. - Market forecasts predict a compound annual growth rate (CAGR) of 12% for revenue and 26% for net profit from 2025 to 2027. The current valuation corresponds to a projected price-to-earnings (PE) ratio of approximately 35 times for 2026 [6]. Summary by Sections Financial Performance - First three quarters revenue: 39.862 billion RMB, down 7.3% YoY; net profit: 3.052 billion RMB, down 22.1% YoY [2]. - Third quarter revenue: 11.711 billion RMB, down 0.4% YoY, an improvement from earlier declines [2]. Market Dynamics - Hainan duty-free sales from July to September: 5.402 billion RMB, down 2.6% YoY, with September showing a 3.4% increase [2]. - Anticipated double-digit growth in October and November due to peak travel season and new store openings [2]. Strategic Developments - Acquisition of DFS's businesses enhances store network and operational synergies [4]. - Expansion of duty-free benefits under Hainan's new policies expected to boost consumer spending [3]. Industry Outlook - Signs of recovery in the luxury goods market positively influencing duty-free consumption [5]. - Projected CAGR of 12% for revenue and 26% for net profit from 2025 to 2027, with potential for valuation re-rating [6].

Investment Rating - The investment rating for the company is downgraded to "Buy" with a target price of HKD 2.3, representing a potential upside of 9% from the current stock price of HKD 2.08 [1][6]. Core Insights - The domestic milk powder business continues to face pressure due to a significant decline in the birth rate, with the 2025 birth population projected at 79.2 million, a 17% year-on-year decrease [1][2]. - The company reported a revenue of RMB 3.89 billion for the first half of 2025, a 5.6% increase year-on-year, and a net profit of RMB 181 million, up 21.4% year-on-year, driven by overseas goat milk powder sales [2][3]. - The gross margin for the first half of 2025 was 41.9%, down 1.5 percentage points year-on-year, with goat milk powder and cow milk powder margins also declining [3]. Financial Summary - Revenue projections for 2025, 2026, and 2027 are adjusted to RMB 2.5 billion, RMB 2.6 billion, and RMB 2.9 billion respectively, with corresponding EPS estimates of HKD 0.16, HKD 0.16, and HKD 0.18 [1][4]. - The company’s financial performance shows a decline in domestic goat milk powder revenue by 8.9% and cow milk powder revenue by 14.9% in the first half of 2025 [2][3]. - The average P/E ratio for comparable companies is estimated at 11.7x, with the company assigned a P/E of 13x due to its overseas business development [12]. Valuation Analysis - The DCF valuation method estimates a reasonable market value of HKD 2.4 based on a WACC of 7.2% and a short-term growth rate of 4% [12]. - The target price of HKD 2.3 is derived from a combination of comparable company analysis and DCF valuation, indicating a potential upside from the current market price [12].

Investment Rating - The report assigns a "Buy" rating to the company, with a current price of HKD 25.24 and a fair value of HKD 27.14 [8]. Core Insights - The company has shown significant internal growth, particularly in its self-operated products, which are expected to continue expanding [2]. - The company reported a total revenue of RMB 2.312 billion for FY26H1, representing a year-on-year growth of 5.72%, and a notable 17% growth when excluding revenue from a specific live-streaming partnership [13]. - The gross profit margin increased by 2.8 percentage points to 36.4%, driven by a rise in self-operated product revenue, which grew by 18.1% to RMB 2 billion, accounting for 52.8% of the total GMV [14]. Summary by Sections 1. FY26H1 Performance - The company achieved a total revenue of RMB 2.312 billion, with a year-on-year increase of 5.72%. Excluding the impact of a specific partnership, the revenue growth was 17% [13]. - The net profit reached RMB 239 million, marking a return to profitability [13]. 2. Main Business Tracking - Self-operated products have expanded significantly, with SKU numbers exceeding 800, becoming a major component of GMV [21]. - The self-operated app's revenue increased from RMB 500 million in FY25H1 to RMB 600 million in FY26H1, indicating a growing preference for self-operated products among paid members [31]. - The company is actively expanding its presence on Douyin (TikTok) with multiple specialized accounts to cover various consumer needs [37]. 3. Profit Forecast and Investment Recommendations - The company is projected to achieve revenues of RMB 4.978 billion and adjusted net profits of RMB 492 million for the fiscal year 2026 [43]. - The report suggests a PE valuation of 52X for the company, leading to a fair market value of RMB 255.81 billion, or HKD 27.14 per share, maintaining the "Buy" rating [43].

Investment Rating - The report does not explicitly state an investment rating for Tencent Holdings [2] Core Insights - Tencent is undergoing a strategic transformation driven by AI, with a focus on organizational restructuring and cloud business profitability milestones. The CEO, Ma Huateng, emphasized that AI is the only area worth significant investment at this time, and the company has successfully transitioned to self-developed products [2][3] - The launch of the "Yuanbao" project marks a significant step in Tencent's "AI + social" strategy, aiming to enhance user engagement through integrated social features and AI capabilities. Tencent plans to invest 1 billion yuan to promote this initiative, targeting exponential growth in AI user numbers during the 2026 Spring Festival [3] - Tencent's gaming business is thriving, with overseas revenue exceeding 10 billion USD, accounting for approximately 30% of total gaming revenue. The company has regained confidence in its core gaming operations, providing stable cash flow and growth potential [4] - In response to challenges in the short drama sector, Tencent Video is shifting towards an "advertising-driven" model while maintaining high-quality long-form content. The company has already produced several successful short drama projects and is exploring new ways to balance content depth and traffic efficiency [5] Summary by Sections Strategic Overview - Tencent's current strategy focuses on AI-driven organizational restructuring and achieving profitability in its cloud business, with a clear commitment to investing in AI technologies [2] AI Initiatives - The "Yuanbao" project represents a critical advancement in Tencent's AI and social strategy, integrating various social features and aiming for significant user growth through substantial promotional investments [3] Gaming Performance - Tencent's gaming division is performing robustly, with a notable increase in overseas revenue, showcasing the company's strong competitive advantage and ability to adapt to market changes [4] Content Strategy - Tencent Video is adapting to market pressures by transitioning to an advertising-driven model while continuing to invest in high-quality content, aiming to leverage its large user base for enhanced revenue generation [5]

Investment Rating - The report assigns a positive investment rating to the company, highlighting its potential in the oncology sector with innovative drug candidates [7][36]. Core Insights - The company, 加科思, focuses on developing targeted therapies for cancer, particularly through its KRAS inhibitors and antibody-drug conjugates (ADCs) [4][8]. - The management team, led by founder Dr. Wang Yinxiang, has extensive experience in drug development, particularly in oncology [2][3]. - 加科思's lead product, 戈来雷塞 (Glecirasib), has been approved for the treatment of KRAS G12C mutation-positive non-small cell lung cancer (NSCLC) in China, marking a significant milestone for the company [10][37]. - The company is advancing multiple clinical trials, including JAB-23E73, a pan-KRAS inhibitor, which is expected to enter pivotal studies in 2026 [36][37]. Company Overview - 加科思 is headquartered in Beijing with additional offices in Shanghai and Boston, employing over 210 staff, primarily in preclinical and clinical development [3]. - The company has established a robust pipeline focusing on the KRAS signaling pathway, with several drug candidates targeting different nodes of this pathway [4][5]. Product Pipeline - The product pipeline includes: - JAB-3312 (SHP2 inhibitor) and Glecirasib (KRAS G12C inhibitor) for NSCLC [12]. - JAB-BX600, a tADC targeting KRAS G12D, which is designed to enhance drug delivery and efficacy [23][24]. - JAB-BX467, an iADC that aims to convert cold tumors into hot tumors by recruiting immune cells [27][28]. Clinical Data - Glecirasib has shown promising clinical results, with a 49.6% objective response rate (ORR) and an 86.3% disease control rate (DCR) in a pivotal study for 2L NSCLC [10][11]. - The combination of Glecirasib and JAB-3312 in first-line NSCLC treatment demonstrated a 71% ORR, significantly outperforming standard therapies [12][13]. Financial Performance - The company reported a 100% increase in revenue for the first half of 2025, driven by sales from Glecirasib and collaboration agreements [35]. - The company maintains a strong cash position, with 1.07 billion yuan in cash and available credit to support ongoing clinical development [35]. Strategic Partnerships - 加科思 has entered into strategic partnerships, including a collaboration with 阿斯利康 for JAB-23E73, which includes significant milestone payments and revenue sharing [37].

业绩再超预期，浆纸一体化驱动价值重构 玖龙纸业(2689) [Table_Industry] 林纸产品 | [Table_Invest] 评级： | 增持 | | --- | --- | | [当前价格 Table_CurPrice] (港元)： | 7.46 | [Table_Market] 交易数据 玖龙纸业公司更新报告 | [姓名table_Authors] | 电话 | 邮箱 | 登记编号 | | --- | --- | --- | --- | | 刘佳昆(分析师) | 021-38038184 | liujiakun@gtht.com | S0880524040004 | | 毛宇翔(分析师) | 021-38038672 | maoyuxiang@gtht.com | S0880524080013 | 本报告导读： 玖龙业绩再超预期，FY26H1 预计盈利 19.5-20.5 亿元，浆纸一体化驱动公司价值重 构 投资要点： | 财务摘要(百万元人民币) | FY2024A | FY2025A | FY2026E | FY2027E | FY2028E | | --- | --- | --- | - ...

Investment Rating - The investment rating for the company is "Accumulate" [5] Core Insights - The company has exceeded performance expectations, with FY26H1 projected earnings between 1.95 billion to 2.05 billion RMB, driven by the integration of pulp and paper operations [2][9] - The integration of pulp and paper production is expected to significantly enhance profitability, with major contributions from new capacities in Hubei and Beihai [9] - The company anticipates further price increases in short-fiber pulp and improvements in profitability for cultural and white card paper, which are currently at historical low levels [9] Financial Summary - Total revenue projections are as follows: - FY2024A: 59.50 billion RMB - FY2025A: 63.24 billion RMB - FY2026E: 69.30 billion RMB - FY2027E: 76.29 billion RMB - FY2028E: 84.02 billion RMB - Revenue growth rates are expected to be 4.9%, 6.3%, 9.6%, 10.1%, and 10.1% respectively [3][10] - Net profit projections are as follows: - FY2024A: 750.68 million RMB - FY2025A: 1.77 billion RMB - FY2026E: 4.00 billion RMB - FY2027E: 4.40 billion RMB - FY2028E: 4.84 billion RMB - Net profit growth rates are expected to be 131.5%, 135.4%, 126.6%, 9.8%, and 10.2% respectively [3][10] - The company’s PE ratio is projected to decrease from 20.31 in FY2024A to 7.23 in FY2028E, indicating increasing valuation attractiveness [3][10] Market Data - The current stock price is 7.46 HKD, with a market capitalization of 35.00 billion HKD and a 52-week price range of 2.82 to 7.46 HKD [6][10]